Gene Expression in Esophageal Cancer
Author Information
Author(s): Hu Nan, Qian Luxia, Hu Ying, Shou Jian-Zhong, Wang Chaoyu, Giffen Carol, Wang Quan-Hong, Wang Yuan, Goldstein Alisa M, Emmert-Buck Michael, Taylor Philip R
Primary Institution: National Cancer Institute
Hypothesis
The study aims to validate the differential mRNA expression of nine selected genes in esophageal squamous cell carcinoma (ESCC) patients.
Conclusion
The study confirms that nine genes are significantly dysregulated in the majority of ESCC cases, suggesting their potential as early detection markers.
Supporting Evidence
- 71% of patients showed increased SPARC expression.
- 70% of patients showed increased Fascin expression.
- 63% of patients showed increased FADD expression.
- 57% of patients showed increased COL7A1 expression.
- 83% of patients showed decreased CK4 expression.
- 77% of patients showed decreased TGM3 expression.
- 73% of patients showed decreased ECM1 expression.
- 67% of patients showed decreased PPL and EVPL expression.
Takeaway
The study looked at how certain genes behave in patients with esophageal cancer, finding that many of them are not working like they should, which could help doctors find cancer earlier.
Methodology
The study used quantitative Real-time RT-PCR to analyze mRNA expression of nine genes in tumor and matched normal tissues from 75 ESCC patients.
Limitations
The study size was modest, and the lack of association with tumor characteristics related to survival suggests limited immediate clinical applications.
Participant Demographics
{"total_participants":75,"males":42,"females":33,"median_age":56}
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website